Skip to main content
  • Français
    • Nederlands
    • English

Home
  • Sign In
  • Domaines thérapeutiques
    • Cardiologie
      • ASCVD
      • Insuffisance Cardiaque
    • Dermatologie
      • Urticaire
    • Hématologie
      • PTI
    • Neurologie
      • Sclérose en plaques
    • Oncologie
      • Cancer du sein
      • Prostate Cancer (mCRPC)
    • Ophtalmologie
      • Maladies de la rétine
    • Respiratoire
    • Rhumatologie
  • Congrès et évenements
    • Cardiologie
      • BSC
      • ESC
    • Dermatologie
      • EADV
      • Sharing is Caring
    • Hématologie
      • ASH
      • EHA
      • ESH
    • Neurologie
      • CMSC
      • EAN
      • ECTRIMS
    • Oncologie
      • ASCO
      • EBCC
      • ESMO
      • SABCS
    • Rhumatologie
      • Sharing is Caring
  • Contactez-nous

Popular Search

  • improved
  • improving
  • aimovig
  • migration
  • migraine

Recent News

RLTech and Nurse Academy
IMPACT event: Innovation and Multidisciplinary care with Pluvicto for Advanced mCRPC patients
Page protected by password
Search
  • PARADIGM-HF

    PARADIGM-HF is the largest study to date in heart failure patients. 1

    Summary:

    The PARADIGM-HF study on systolic heart failure with 8,399 patients in NYHA class II-IV. 2,3...

    Twitter Linkedin Facebook Pinterest Google plus
  • PIONEER-HF

    The recently presented PIONEER-HF studies the efficacy and safety of initiating ENTRESTO compared to enalapril prior to discharge after hospitalization for an acute decompensated heart failure episode. 1 The results of PIONEER-HF...

    Twitter Linkedin Facebook Pinterest Google plus
  • Efficacy - Entresto

    ENTRESTO ® achieved superior outcomes vs Enalapril in the largest trial ever conducted in HF
    Twitter Linkedin Facebook Pinterest Google plus
  • Mechanism of Action - Entresto

    Sacubitril/valsartan, a first-in-class ARNI, delivers simultaneous inhibition of neprilysin and blockade of the AT1 receptor. Sacubitril/valsartan is a sodium salt complex comprising sacubitril (AHU377), a prodrug, which is further metabolized to the...

    Twitter Linkedin Facebook Pinterest Google plus
  • Cosentyx zelf-injectie gids

      Download Dutch version     .field-name-field-np4-expiry-date {display:none;}
  • Guide d'autoinjection du Cosentyx

      Download French version     .field-name-field-np4-expiry-date {display:none;}
  • Indications - Entresto

    ENTRESTO ® is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction. ENTRESTO is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic...

    Twitter Linkedin Facebook Pinterest Google plus
  • Patient Resources - Entresto

    Together for Better In the fight against heart failure condition, we work our hardest every day to develop innovative and effective medication to sustain a better life, keeping the patient in mind. We are aware that the result of...

    Twitter Linkedin Facebook Pinterest Google plus
  • ENTRESTO®: Medication Diary ( French)

    This booklet has been developed to help patients to manage heart failure better monitored and managed.     To receive by post, click on the "Add to card" button below .field-name-field-np4-expiry-date {display:none;}
  • ENTRESTO®: Medication Diary ( Dutch)

    This booklet has been developed to help patients to manage heart failure better monitored and managed.     .field-name-field-np4-expiry-date {display:none;} To receive by post, click on the "Add to card" button below
  • previous
page 

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
 of  15
  • next

Filter by spécialité:

S’abonner à Novartis

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Plan du site
Cookie Settings
©2025 Novartis Belgique & Luxembourg
  • Conditions d'utilisation
  • Politique de protection des données personnelles
  • Cookies
Ce site Internet s’adresse aux professionnels de la santé basés en Belgique & Luxembourg